TEST IT Gel ABO/CDE (DVI+) & Reverse

ABO
The ABO system is the most important blood group system in transfusion practice and was the first human blood group system to be discovered by Landsteiner in 1900. The ABO blood group is defined by the presence or absence of the A and/or B antigens on the surface of human red blood cells and by the presence or absence of antibodies in the serum corresponding to the antigen or antigens missing in the red blood cells. The human blood group is determined directly by testing the red blood cells with known anti-A and anti-B reagent, known as forward grouping.
Reverse
The results of the human blood group should be confirmed by detecting the presence or absence of corresponding antibodies in serum using known A1 and B red blood cells, known as reverse grouping. The determination of human blood groups should be performed to include both forward and reverse grouping tests.
Rh ((D, C and E antigens)
After the A and B antigens of the ABO blood group system, D is the most important blood group antigen in transfusion practice. The terms "Rh-positive" and "Rh-negative" refer to the presence or absence of the D (Rho) red blood cell antigen. The D antigen is one of many that comprise the Rh blood group system. The presence or absence of the D antigen is determi- ned by testing the red blood cells with Anti-D. Some individuals have a variant Rh(D) gene that red blood cells have all epitopes of D but expressed weakly(weak D) or red blood cells have some missing D epitopes (partial D).2 Various anti-D reagents react dierently with these red cells and provide interpreting Rh(D) type. The Rh antigens C (RH2) and / or E (RH3) may be present on red cells with or without the presence of D (RH1) antigens. The presence of either C and / or E antigens can be determined by the use of an anti-CDE reagent.

Release form

Quantity

Price

{{ item.price }} UAH
Total {{ Vue.prototype.totalP }}
UAH

Product Description

Producer:

TÜRKLAB TIBBI MALZEMELER SAN VE TIC A.Ş.

Country of production:

TURKEY

Article:

TG103

Brief description:

ABO
The ABO system is the most important blood group system in transfusion practice and was the first human blood group system to be discovered by Landsteiner in 1900. The ABO blood group is defined by the presence or absence of the A and/or B antigens on the surface of human red blood cells and by the presence or absence of antibodies in the serum corresponding to the antigen or antigens missing in the red blood cells. The human blood group is determined directly by testing the red blood cells with known anti-A and anti-B reagent, known as forward grouping.
Reverse
The results of the human blood group should be confirmed by detecting the presence or absence of corresponding antibodies in serum using known A1 and B red blood cells, known as reverse grouping. The determination of human blood groups should be performed to include both forward and reverse grouping tests.
Rh ((D, C and E antigens)
After the A and B antigens of the ABO blood group system, D is the most important blood group antigen in transfusion practice. The terms "Rh-positive" and "Rh-negative" refer to the presence or absence of the D (Rho) red blood cell antigen. The D antigen is one of many that comprise the Rh blood group system. The presence or absence of the D antigen is determi- ned by testing the red blood cells with Anti-D. Some individuals have a variant Rh(D) gene that red blood cells have all epitopes of D but expressed weakly(weak D) or red blood cells have some missing D epitopes (partial D).2 Various anti-D reagents react dierently with these red cells and provide interpreting Rh(D) type. The Rh antigens C (RH2) and / or E (RH3) may be present on red cells with or without the presence of D (RH1) antigens. The presence of either C and / or E antigens can be determined by the use of an anti-CDE reagent.

Appointment:

For the determination of the ABO and D(RH1), C(RH2), E(RH3) antigen grouping and reverse grouping of ABO on a single Gel Card with the gel method in human blood samples. DVI+ microtubes detect presence of Weak D/Partial D antigens.

Materials provided:

Gel cards and instructions for use.

Materials required but not provided:

TEST IT Cell Reverse A1-B; 0,8% red blood cell suspension, in 10 ml vial, ready to use
TEST IT LISS Solution
Pipette
Disposable pipette tips
Disposable tubes for suspension
Gel Card Centrifuge [Centrifugation time & speed: 990 rpm (130 x g) / 9 minutes]

Delivery

Implemented by Nova Poshta. If the order is above 1500 UAH, the sender pays the shipping cost